MethyLPREDNISolone Acetate Injectable Suspension, USP, 200 mg/5 mL (40 mg/mL), 5 mL Multiple Dose Vial, Rx only, MFG: NorthstarRx/Teva Pharma USA , NDC 16714-089-01
Recall Number: D-1062-2022
Firm: Mckesson Medical-Surgical Inc. Corporate Office
Classification: Class II
Status: Terminated
Report Date: 20220615
Initiation Date: 20220413
Termination Date: 20231130
Reason for Recall
cGMP deviations: Temperature abuse
Product Description
MethyLPREDNISolone Acetate Injectable Suspension, USP, 200 mg/5 mL (40 mg/mL), 5 mL Multiple Dose Vial, Rx only, MFG: NorthstarRx/Teva Pharma USA , NDC 16714-089-01